GW273297X
GW273297X is a CYP27A1 inhibitor. GW273297X reduces 27HC concentration in E0771 tumors in APOE3 mice. GW273297X can be used in breast cancer research[1].
Product Specifications
CAS Number
1713317-28-2
Product Name Alternative
G297X
UNSPSC
12352211
Target
Cytochrome P450
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
C[C@@]12[C@]3([H])[C@]([C@@H](C[C@]1([H])CC(OC)(CC2)OC)O)([H])[C@@]4([H])[C@](CC3)([C@H](CC4)[C@H](C)CCCCC#C)C
Molecular Formula
C29H48O3
Molecular Weight
444.69
References & Citations
[1]Donald P. Mcdonnell, et al. Use of cyp27a1 inhibitors, statin, or lxr antagonists alone or in combination with conventional therapy for the treatment of breast cancer. WO2015065505A1. Duke University. 2014-01-03.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY400162 100 µg
HNF1 beta (HNF1B) (NM_000458) Human Over-expression Lysate
Sign In for Pricing
View Details 
HP221229 200 Reactions
LOC256233 Human qPCR Primer Pair (XM_172471)
Sign In for Pricing
View Details 